drugset / Trial / NCT00231517

Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa

NCT00231517

Phase 4 Completed Institute of Child Health
RandomizedCrossoverDouble-blindTreatment

Summary

Randomised Double blind placebo controlled cross over design study of the efficacy of morphine for inflammatory pain in children with Epidermolysis Bullosa

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified Topical

Indications